Polymer Microparticles Prolong Delivery of the 15-PGDH Inhibitor SW033291

As the prevalence of age-related fibrotic diseases continues to increase, novel antifibrotic therapies are emerging to address clinical needs. However, many novel therapeutics for managing chronic fibrosis are small-molecule drugs that require frequent dosing to attain effective concentrations. Alth...

Descripción completa

Detalles Bibliográficos
Autores principales: Dogan, Alan B., Rohner, Nathan A., Smith, Julianne N. P., Kilgore, Jessica A., Williams, Noelle S., Markowitz, Sanford D., von Recum, Horst A., Desai, Amar B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779392/
https://www.ncbi.nlm.nih.gov/pubmed/35056981
http://dx.doi.org/10.3390/pharmaceutics14010085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779392/
https://www.ncbi.nlm.nih.gov/pubmed/35056981
http://dx.doi.org/10.3390/pharmaceutics14010085

Ejemplares similares